Detalhe da pesquisa
1.
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia.
Blood
; 140(21): 2228-2247, 2022 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36130297
2.
Diagnostic challenges and proposed classification of myeloid neoplasms with overlapping features of thrombocytosis, ring sideroblasts and concurrent del(5q) and SF3B1 mutations.
Haematologica
; 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38572547
3.
Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignancies.
Haematologica
; 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38450530
4.
Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations.
Nature
; 559(7712): 125-129, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29950729
5.
Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRASG12C-Mutant Non-Small Cell Lung Cancer.
Oncologist
; 28(11): 978-985, 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37589215
6.
Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia.
Blood
; 137(10): 1377-1391, 2021 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32871587
7.
Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia.
Am J Hematol
; 98(1): 79-89, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36251406
8.
A Rare Case of Primary Cutaneous Gamma-Delta T-cell Lymphoma with Aberrant B-cell Marker Expression.
Am J Dermatopathol
; 45(11): 768-772, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37856740
9.
ERBB2 amplification status in 67 salivary duct carcinomas assessed by immunohistochemistry, fluorescence in situ hybridization, and targeted exome sequencing.
Mod Pathol
; 35(7): 895-902, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34963694
10.
Androgen receptor splice variant-7 in breast cancer: clinical and pathologic correlations.
Mod Pathol
; 35(3): 396-402, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34593966
11.
Rare and novel RUNX1 fusions in myeloid neoplasms: A single-institute experience.
Genes Chromosomes Cancer
; 60(2): 100-107, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33078873
12.
Next-generation assessment of human epidermal growth factor receptor 2 gene (ERBB2) amplification status in invasive breast carcinoma: a focus on Group 4 by use of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 testing guideline.
Histopathology
; 78(4): 498-507, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32841416
13.
Next generation sequencing of breast implant-associated anaplastic large cell lymphomas reveals a novel STAT3-JAK2 fusion among other activating genetic alterations within the JAK-STAT pathway.
Breast J
; 27(4): 314-321, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33660353
14.
Sclerosing epithelioid mesenchymal neoplasm of the pancreas - a proposed new entity.
Mod Pathol
; 33(3): 456-467, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31383964
15.
Frequency and outcomes of brain metastases in patients with HER2-mutant lung cancers.
Cancer
; 125(24): 4380-4387, 2019 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31469421
16.
JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management.
Mod Pathol
; 32(9): 1344-1358, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30996253
17.
Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma.
Am J Hematol
; 94(12): 1364-1373, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31571261
18.
Lessons learned from routine, targeted assessment of liquid biopsies for EGFR T790M resistance mutation in patients with EGFR mutant lung cancers.
Acta Oncol
; 58(11): 1634-1639, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31347936
19.
The value of cell-free DNA for molecular pathology.
J Pathol
; 244(5): 616-627, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29380875
20.
CDKN2A/B mutations and allele-specific alterations stratify survival outcomes in IDH-mutant astrocytomas.
Acta Neuropathol
; 146(6): 845-847, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37831210